Most of you are used to getting a Pap smear during your annual visit to the gynecologist, but now some health authorities are recommending the age-old Pap be replaced by a new test designed to detect cervical cell abnormalities just about the time they start up.
So, although the Pap test, which has been the gold standard for diagnosing cervical cancer since the 1950’s is still around, there might be something new on the horizon. You might be asking yourself, ‘why,’ since the National Cancer Institute says the Pap, named after Greek doctor Georgios Papanikolaou, has helped reduce certain cervical cancers by up to 80%.
The NCCC (National Cervical Cancer Coalition) says that cervical cancer is very preventable and in fact can be prevented through early diagnosis and appropriate treatment of certain cells that become abnormal when impacted by the human papillomavirus (HPV); this is a process which begins long before the actual cancer develops. The Pap has been the topline test for HPV, but there are other, perhaps even better, options to spot the troublesome cells in women starting at an earlier age, according to one government agency.
The FDA has recommended a replacement screen to detect gynecological cancers, suggesting that the Pap is soon to become a thing of the past. Does this mean that the days of lying on your back, scooting your bottom down to the end of the table, putting your feet in stirrups and waiting for the swab might be coming to a close? Not necessarily.
The “Quiet Virus”
Physicians have known for some time that there is a critical link between cervical cancer and the human papilloma virus (HPV), which is transmitted via sexual intimacy and has a tendency to hang around like a bad boyfriend.
HPV is not very common after the age of 30, but if you test positive for this virus, you may have gotten it many years before and your immune system is still showing positive. HPV causes changes at the cellular level only after it’s invaded and been in your system for a while. That is why testing after age 30 is beneficial.
Recently, the FDA issued guidelines indicating the agency is ready to recognize the Roche HPV DNA test as the frontline check for women over the age of 25. According to the FDA, this specialized DNA test provides not only a current snapshot of the health of your cervix, which is located at the bottom of your uterus, but also provides important information about your risk for developing cervical cancer in the future. It works by detecting DNA from 14 high-risk HPV types, identifying HPV 16 and 18, as well as 12 other types of high-risk HPVs. Doctors get the DNA by swabbing your cervix, much like the traditional Pap.
If you test positive for HPV 16 or 18, the agency recommends a colposcopy, which lights up and magnifies your cervix, so that your doctor can more closely observe what’s going on with your cervical cells. If you test positive for one of the other types of HPV, then it’s recommended you have a Pap test to determine your need for the colposcopy.
One study, the ATHENA (Addressing the Need for Advanced HPV Diagnostics) found that taking a random biopsy at the time of the colposcopy was even more effective in detecting cervical cancer, whether there were visible lesions, or not. In other words, the Pap smear might become just a part of, and not the centerpiece of, your annual pelvic exam.
But Wait—There’s More
Now several groups of physicians believe that bimanual palpation of your uterus and internal organs (when your doctor inserts two fingers and feels around your abdominal area) is not only unnecessary in most cases but also intrusive enough to cause some patients anxiety.
This past summer, the American College of Physicians (ACP) came out against routine pelvic exams which involve bimanual palpation, but only in women who are not at high risk for certain cancers, such as uterine or ovarian and those who are not pregnant, because the organization says this particular exam is not effective in detecting cervical cancers.
Those same guidelines do recommend regular exams of the cervix such as Pap smears because the Pap is still very effective in detecting cervical cancer in early stages. However, the actual exam during which your doctor inserts two fingers into your vagina and checks the abdomen is not necessary, with ACP co-author Dr. Linda Humphrey stating specifically that it, “Rarely detects important disease and does not reduce mortality and is associate with discomfort for many women, false positive and negative examinations, and extra cost.”
The ACP, which is the second largest physician group in the country, agreed that the diagnostic accuracy for detecting cancers utilizing this method is very low.
The American Congress of Gynecology and Obstetrics (ACOG) had a varying viewpoint insisting that women should continue to get annual pelvic exams including bimanual palpitation, but acknowledged that the decision to include all components of the exam rested with both the patient and her physician. ACOG, the leading group of physicians providing healthcare for women, says these ‘well-woman visits’ are an important part of the patient physician relationship and along with breast exams, immunizations and contraceptive care discussions help nurture that relationship and ensuing trust.
I chatted with Dr. Rebecca C. Brightman, assistant clinical professor OBGYN and Reproductive Science at the Mount Sinai School of Medicine in New York City, who says, “It is very important for women to realize that the Pap smear is only a portion of the annual gynecologic examination. An annual (and for some patients semiannual) evaluation of a woman’s thyroid, breasts and pelvic organs remains essential.”
Dr. Brightman also notes that for some women, their OBGYN might be the one and only healthcare provider. She further explains, “As an OBGYN, we frequently screen for and diagnose other medical conditions. Women confide in their OBGYNs and seek advice in many areas from mental health concerns to social problems. So, it’s way more than just a pap smear!”
Once again, the patient-doctor relationship is so important to a healthier you!
Which Way Should You Go?
Like anything else in life, it pays to be informed about your own gynecological health, although it can be difficult to find a blanket one-size-fits-all answer. Some experts say that if you are a woman with an average risk of cervical cancer, then this is the route to follow:
- Ages 21 to 29: a Pap smear once every 3 years
- Ages 30 to 65: Pap smear every 3 years or/combination Pap smear and HPV test every 5 years
- Over age 65: routine Pap screening not needed if recent tests have been normal.
Bottom line—it’s all up to you whether you’ll stick with just the Pap or ask for the HPV diagnostics, as well.
As always, check with your doctor and reach a collaborative decision. It’s the best approach to feeling good and staying healthy, all the way through the ‘change.
Suffering in Silence is Out! Reaching Out is In!